loading

Briacell Therapeutics Corp Stock (BCTX) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-01-31 2023-10-31 2023-07-31 2023-04-30 2023-01-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
15.60%
9.8294
8.503 - 5.677 4.4863
Depreciation and Amortization
0.03%
0.00382
0.00382 - - -
Operating Income/Loss
15.60%
-9.8294
-8.503 -7.7058 -5.677 -4.4863
Nonoperating Income/Loss
110.28%
-1.4861
14.46 5.2871 0.7816 -7.3954
Income/Loss From Continuing Operations Before Tax
290.20%
-11.33
5.9589 -2.4187 -4.8954 -11.88
Income/Loss From Continuing Operations After Tax
290.20%
-11.33
5.9589 -2.4187 -4.8954 -11.88
Net Income/Loss
290.20%
-11.33
5.9589 -2.4187 -4.8954 -11.88
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
7.88%
-0.0393
-0.0427 - - -
Basic Average Shares
0.00%
15.98
15.98 0.1016 15.52 15.52
Diluted Average Shares
4.16%
15.98
16.67 0.1016 15.52 15.52
Basic Earnings Per Share
286.84%
-0.71
0.38 - - -0.77
Diluted Earnings Per Share
42.00%
-0.71
-0.50 -0.15 -0.32 -0.77
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.94
price down icon 1.35%
$75.45
price up icon 0.87%
$43.39
price up icon 3.19%
$378.13
price up icon 0.30%
$206.16
price up icon 7.31%
$120.72
price up icon 1.84%
Cap:     |  Volume (24h):